title: The 2016 Lasker-DeBakey Clinical Medical Research Award: Innovative hepatitis C virus (HCV) replicons leading to drug development for hepatitis C cure.
authors: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, China. zhaoqinjian@xmu.edu.cn.
authors: Qinjian
authors: Q
authors: Zhao
authors: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, China. nsxia@xmu.edu.cn.|National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, China. nsxia@xmu.edu.cn.
authors: Ningshao
authors: N
authors: Xia
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001363:Awards and Prizes; D035843:Biomedical Research; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D006526:Hepatitis C / Q000188:drug therapy* / Q000821:virology; D054884:Host-Pathogen Interactions / Q000187:drug effects; D006801:Humans; D012093:Replicon / Q000235:genetics; D000069474:Sofosbuvir / Q000627:therapeutic use*; D014779:Virus Replication / Q000187:drug effects* / Q000235:genetics
chemical_list: D000998:Antiviral Agents; D000069474:Sofosbuvir